References
- Schalm SW, Summerskill WH, Gitnick GL, et al. Contrasting features and responses to treatment of severe chronic active liver disease with and without hepatitis BS antigen. Gut 1976: 17(10): 781–6
- Kanel GC, Govindarajan S, Peters RL. Chronic delta infection and liver biopsy changes in chronic active hepatitis B. Ann Intern Med 1984: 101 (1): 51–4
- Aach RD, Kahn RA. Post-transfusion hepatitis: current perspectives. Ann Intern Med 1980: 92(4): 539–46
- Seeff LB. Drug-induced chronic liver disease, with emphasis on chronic active hepatitis. Semin Liver Dis 1981: 1(2): 104–15
- Nouri-Aria KT, Hegarty JE, Alexander GJ, et al. Effect of corticosteroids on suppressor-cell activity In “autoimmune” and viral chronic active hepatitis. N Engl J Med 1982: 307(21): 1301
- Czaja AJ. Diagnosis and treatment of chronic hepatitis. Compr Ther 1984: 10(10): 58–63
- Hazzi C. Diagnosis and management of chronic active hepatitis. Am J Gastroenterol 1986: 81(1): 85–90
- Hoofnagle JH, Davis GL, Pappas SC, et al. A short course of prednisolone in chronic type B hepatitis: report of a randomized, double-blind, placebo-controlled trial. Ann Intern Med 1986: 104(1): 12–7
- Czaja AJ. Natural history, clinical features, and treatment of autoimmune hepatitis. Semin Liver Dis 1984: 4(1): 1–12
- Hoofnagle JH. Antiviral treatment of chronic type B hepatitis. Ann Intern Med 1987: 107(3): 413–5
- Hoofnagle JH, Peters M, Mullen KD, et al. Randomized, controlled trial of recombinant human alpha-interferon in patients with chronic hepatitis B. Gastroenterology 1988: 95(5): 1318–25
- Hoofnagle JH, Mullen KD, Jones DB, et al. Treatment of chronic non-A, non-B hepatitis with recombinant human alpha interferon: a preliminary report. N Engl J Med 1986: 315(25): 1575–8
- Sherlock S, Thomas HC. Treatment of chronic hepatitis due to hepatitis B virus. Lancet 1985: 2(8468): 1343–6
- Soloway RD, Summerskill WH, Baggenstoss AH, et al. Clinical, biochemical, and histological remission of severe chronic active liver disease: a controlled study of treatments and early prognosis. Gastroenterology 1972: 63(5): 820–33
- Czaja AJ, Ammon HV, Summerskill WH. Clinical features and prognosis of severe chronic active liver disease (C ALD) after corticosteroid-induced remission. Gastroenterology 1980: 78(3): 518–23
- Blum HE, Offensperger WB, Walter E, et al. Hepatocellular carcinoma and hepatitis B virus infection: molecular evidence for monoclonal origin and expansion of malignantly transformed hepatocytes. J Cancer Res Clin Oncol 1987: 113(5): 466–72